Results 171 to 180 of about 66,048 (291)

Incidence and Long‐Term Outcomes of Pouchitis in Ulcerative Colitis Patients

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background Ileal pouch‐anal anastomosis (IPAA) is the preferred intervention for ulcerative colitis (UC) patients whose medical treatment fails. Acute severe ulcerative colitis (ASUC) can precipitate the need for urgent surgery, potentially influencing post‐IPAA outcomes.
Rosalina Bergstrøm   +8 more
wiley   +1 more source

Pancytopenia related to azathioprine in rheumatoid arthritis. [PDF]

open access: bronze, 1988
M. E. C. Jeurissen   +2 more
openalex   +1 more source

Treatment of Neurogenic Voice Disorders

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT This overview serves as a foundational resource for clinicians caring for neurologically complex patients presenting with voice complaints. Neurogenic voice disorders are diverse in their clinical presentations and therapeutic approaches. A thorough medical history, including family history, detailed laryngeal examination, voice assessments ...
Mausumi Syamal
wiley   +1 more source

Rituximab Therapy in Refractory Ocular Cicatricial Pemphigoid: A Case Report. [PDF]

open access: yesReports (MDPI)
Pauk SV   +4 more
europepmc   +1 more source

Outcomes of Fecal Diversion in Perianal Crohn's Disease: A Systematic Review and Meta‐Analysis

open access: yesJournal of Digestive Diseases, EarlyView.
Fecal diversion provides symptom control in patients with perianal fistulising Crohn’s disease, with a 65% clinical improvement rate. However, bowel restoration is achieved in only 29% of cases, and many require re‐diversion or proctectomy/protocolectomy.
Imogen Hartley   +4 more
wiley   +1 more source

National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel. [PDF]

open access: yesTher Adv Neurol Disord
Shelly S   +9 more
europepmc   +1 more source

IMMUNOSUPPRESSION WITH AZATHIOPRINE, PREDNISONE, AND CYCLOPHOSPHAMIDE1

open access: bronze, 1979
John Jeffery   +3 more
openalex   +1 more source

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Janus kinase inhibitors (JAKis) have been approved by the Therapeutic Goods Administration for severe alopecia areata (AA) in Australia. However, access is limited as JAKis are not currently subsidised on the Pharmaceutical Benefits Scheme for this indication. This study aimed to establish expert consensus on criteria for
Meryl Thomas   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy